keyboard_arrow_up

Research delivers insight into the US Market for Bone Graft Substitutes 2011-2021

US Market for Bone Graft Substitutes 2011-2021 is a new market research publication announced by Reportstack. The bone graft substitute market competes with both the growth factor market, which is currently only comprises INFUSE®, and the stem cell graft market. Due to the declining usage of INFUSE®, the use of bone graft substitute use has increased. The rise of cell therapy products, including platelet-rich-plasma and bone marrow concentrate, has also aided the growth of the bone graft substitute market, especially in the segments for demineralized bone matrices and synthetic grafts. Platelet-rich plasma provides growth factors when a graft is soaked in it; bone marrow concentrate provides stem cells. This complementary use allows bone graft substitutes to better compete with the growth factors and stem cell grafts.

Scope
2011-2021


Companies Mentioned

Medtronic DePuy Synthes Stryker Integra LifeSciences RTI Surgical MTF AlloSource Baxter Biomet Wright Medical Bacterin International LifeNet Health Biocomposites Exactech Arthrex Alphatec Spine

To view the table of contents and know more details, please visit  US Market for Bone Graft Substitutes 2011-2021.

Snapshot of TOC

TABLE OF CONTENTS I
LIST OF FIGURES V
LIST OF CHARTS IX
RESEARCH METHODOLOGY 1
1.1 RESEARCH SCOPE 1
1.2 IDATA’S 9-STEP METHODOLOGY 1
Step 1: Project Initiation & Team Selection 1
Step 2: Prepare Data Systems and Perform Secondary Research 3
Step 3: Preparation for Interviews & Questionnaire Design 4
Step 4: Performing Primary Research 5
Step 5: Research Analysis: Establishing Baseline Estimates 7
Step 6: Market Forecast and Analysis 8
Step 7: Identify Strategic Opportunities 10
Step 8: Final Review and Market Release 11
Step 9: Customer Feedback and Market Monitoring 12
ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET 13
2.1 INTRODUCTION 13
2.2 MARKET SEGMENTATION 14
2.2.1 By Indication 14
2.2.1.1 Spine 14
2.2.1.2 Trauma 15
2.2.1.3 Large Joint 15
2.2.1.4 Foot Reconstruction 15
2.2.1.5 Craniomaxillofacial 15
2.2.1.6 Oncology 15
2.2.2 By Material 15
2.2.2.1 Autograft 15
2.2.2.2 Standard Allograft 15
2.2.2.3 Demineralized Bone Matrix 16
2.2.2.4 Synthetic 16
2.2.2.5 Xenograft 16
2.3 PROCEDURE NUMBERS 17
2.3.1 Bone Graft Substitutes Procedure Numbers by Material 17
2.3.2 Units Per Procedure by Indication 19
2.4 MARKET OVERVIEW 20
2.4.1 Bone Graft Substitute Market by Material 20
2.4.2 Bone Graft Substitute Market by Indication 24
2.5 MARKET ANALYSIS AND FORECAST 28
2.5.1 Total Orthopedic Bone Graft Substitute Market 28
2.5.2 Bone Graft Substitute Market by Material 30
2.5.2.1 Total Allograft Bone Graft Substitute Market 30
2.5.2.2 Allograft Bone Graft Substitute Market by Indication 32
2.5.2.2.1 Spine 33
2.5.2.2.1.1 Cervical Spine 34
2.5.2.2.1.2 Thoracolumbar Spine 35
2.5.2.2.2 Trauma 36
2.5.2.2.2.1 Non-union Trauma 37
2.5.2.2.2.2 Fresh Fracture Trauma 38
2.5.2.2.3 Large Joint Reconstruction 39
2.5.2.2.3.1 Hip Large Joint Reconstruction 40
2.5.2.2.3.2 Knee Large Joint Reconstruction 41
2.5.2.2.4 Foot Reconstruction 42
2.5.2.2.5 Craniomaxillofacial 43
2.5.2.2.6 Oncology 44
2.5.2.3 Total Demineralized Bone Matrix Market 45
2.5.2.4 Demineralized Bone Matrix Market, with and without Carriers 47
2.5.2.5 Demineralized Bone Matrix Market by Indication 48
2.5.2.5.1 Spine 49
2.5.2.5.1.1 Cervical Spine 50
2.5.2.5.1.2 Thoracolumbar Spine 51
2.5.2.5.2 Trauma 52
2.5.2.5.2.1 Non-union Trauma 53
2.5.2.5.2.2 Fresh Fracture Trauma 54
2.5.2.5.3 Large Joint Reconstruction 55
2.5.2.5.3.1 Hip Large Joint Reconstruction 56
2.5.2.5.3.2 Knee Large Joint Reconstruction 57
2.5.2.5.4 Foot Reconstruction 58
2.5.2.5.5 Craniomaxillofacial 59
2.5.2.5.6 Oncology 60
2.5.2.6 Total Synthetic Bone Graft Substitute Market 61
2.5.2.7 Synthetic Bone Graft Substitute Market by Indication 63
2.5.2.7.1 Spine 64
2.5.2.7.1.1 Cervical Spine 65
2.5.2.7.1.2 Thoracolumbar Spine 66
2.5.2.7.2 Trauma 67
2.5.2.7.2.1 Non-union Trauma 68
2.5.2.7.2.2 Fresh Fracture Trauma 69
2.5.2.7.3 Large Joint Reconstruction 70
2.5.2.7.3.1 Hip Large Joint Reconstruction 71
2.5.2.7.3.2 Knee Large Joint Reconstruction 72
2.5.2.7.4 Foot Reconstruction 73
2.5.2.7.5 Craniomaxillofacial 74
2.5.2.7.6 Oncology 75
2.5.3 Bone Graft Substitute Market by Indication 76
2.5.3.1 Spine Bone Graft Substitute Market 76
2.5.3.1.1 Cervical Spine Bone Graft Substitute Market 78
2.5.3.1.2 Thoracolumbar Spine Bone Graft Substitute Market 80
2.5.3.2 Trauma Bone Graft Substitute Market 82
2.5.3.2.1 Non-union Trauma Fracture Bone Graft Substitute Market 84
2.5.3.2.2 Fresh Fracture Trauma Bone Graft Substitute Market 85
2.5.3.3 Large Joint Reconstruction Bone Graft Substitute Market 86
2.5.3.3.1 Hip Large Joint Reconstruction Bone Graft Substitute Market 88
2.5.3.3.2 Knee Large Joint Reconstruction Bone Graft Substitute Market 89
2.5.3.4 Foot Reconstruction Bone Graft Substitute Market 90
2.5.3.5 Craniomaxillofacial Bone Graft Substitute Market 92
2.5.3.6 Oncology Bone Graft Substitute Market 94
2.6 DRIVERS AND LIMITERS 96
2.6.1 Market Drivers 96
2.6.1.1 Allograft Bone Graft Substitute Market 96
2.6.1.2 Demineralized Bone Matrix Bone Graft Substitute Market 96
2.6.1.3 Synthetic Bone Graft Substitute Market 97
2.6.2 Market Limiters 99
2.6.2.1 Allograft Bone Graft Substitute Market 99
2.6.2.2 Demineralized Bone Matrix Bone Graft Substitute Market 99
2.6.2.3 Synthetic Bone Graft Substitute Market 99
2.7 COMPETITIVE ANALYSIS 101
ABBREVIATIONS 109

Contact:

Debora White
Manager - Marketing 
debora@reportstack.com
Ph: +1-888-789-6604
Reportstack Market Research
###